Literature DB >> 3089438

Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis.

M Goldman, C Liesnard, J L Vanherweghem, N Dolle, C Toussaint, S Sprecher, J Cogniaux, L Thiry.   

Abstract

Patients and members of staff from a haemodialysis unit were tested for markers of infection with human T cell lymphotropic virus type III (HTLV-III), the virus associated with the acquired immune deficiency syndrome (AIDS). An enzyme linked immunosorbent assay showed eight of 100 patients to have antibodies to HTLV-III. In five of these patients past or present infection with HTLV-III was confirmed by Western blot analysis or detection of HTLV-III antigens in lymphocyte cultures, or both. Investigation of other risk factors for AIDS showed that the putative source of HTLV-III was unrelated to dialysis in two patients whereas blood transfusion was the most likely cause of contamination in the others. No member of staff gave a positive result in the enzyme linked immunosorbent assay. Nosocomial transmission of HTLV-III seems unlikely if precautions similar to those recommended for the control of hepatitis B infection are applied.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089438      PMCID: PMC1340904          DOI: 10.1136/bmj.293.6540.161

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  4 in total

1.  HTLV-III antibodies in patients with kidney transplants or on haemodialysis.

Authors:  H H Neumayer; K Wagner; S Kresse
Journal:  Lancet       Date:  1986-03-01       Impact factor: 79.321

2.  Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.

Authors:  P M Feorino; H W Jaffe; E Palmer; T A Peterman; D P Francis; V S Kalyanaraman; R A Weinstein; R L Stoneburner; W J Alexander; C Raevsky
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

3.  Development and early natural history of HTLV-III antibodies in persons with hemophilia.

Authors:  M E Eyster; J J Goedert; M G Sarngadharan; S H Weiss; R C Gallo; W A Blattner
Journal:  JAMA       Date:  1985-04-19       Impact factor: 56.272

4.  Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis.

Authors:  M S Favero
Journal:  Infect Control       Date:  1985-08
  4 in total
  3 in total

1.  Markers of HTLV-III in patients with end stage renal failure.

Authors:  R S Rodger; J S Tapson; A A Codd
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

2.  Interpretation of bronchograms and chest radiographs in patients with chronic sputum production.

Authors:  D C Currie; J C Cooke; A D Morgan; I H Kerr; D Delany; B Strickland; P J Cole
Journal:  Thorax       Date:  1987-04       Impact factor: 9.139

Review 3.  Risk and management of blood-borne infections in health care workers.

Authors:  E M Beltrami; I T Williams; C N Shapiro; M E Chamberland
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.